Efficacy and Safety of Hematopoietic Stem Cell Remobilization With Plerixafor (Mozobil®) + G-CSF in Patients With Germ Cell Tumor

J. Schriber, M. Horwitz, E. Libby, D. Huebner, P.D. Mody, P. Holman
2011 Biology of Blood and Marrow Transplantation  
39kg/M2. A more objective secondary analysis divided our patients' BMI into quartiles was also used to explore risk threshold. Results: The median BMI for our entire population was 33.9 (15.6-57.6). The 100 day mortality in the myeloma and NHL patients were 4/153 (2.6%) and 2/72 (2.7%), respectively. Using the above literature driven definitions, the data showed a significantly higher mortality with increasing obesity (p \ 0.0001, see Table) .
doi:10.1016/j.bbmt.2010.12.163 fatcat:tgbp2lh4lzdwpkcl5bg4iqg7l4